These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11185546)

  • 1. First report of ampicillin and glycopeptide resistant Enterococcus faecium VanA bacteraemia in Greece.
    Kouppari G; Papadaki H; Arida C; Sakellariou J; Legakis NJ; Papaparaskevas J
    Int J Antimicrob Agents; 2000 Nov; 16(3):254-6. PubMed ID: 11185546
    [No Abstract]   [Full Text] [Related]  

  • 2. First description in Europe of the emergence of Enterococcus faecium ST117 carrying both vanA and vanB genes, isolated in Greece.
    Papagiannitsis CC; Malli E; Florou Z; Medvecky M; Sarrou S; Hrabak J; Petinaki E
    J Glob Antimicrob Resist; 2017 Dec; 11():68-70. PubMed ID: 28754459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different VanA Elements in E. faecalis and in E. faecium Suggest at Least Two Origins of Tn1546 Among VRE in a Brazilian Hospital.
    Merlo TP; Dabul AN; Camargo IL
    Microb Drug Resist; 2015 Jun; 21(3):320-8. PubMed ID: 25588068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
    Weinstein MP
    J Clin Microbiol; 2001 Jul; 39(7):2729-31. PubMed ID: 11427608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and transfer of the vanA cluster in vanA-positive, vancomycin-susceptible Enterococcus faecium, and its revertant mutant.
    Jung YH; Lee YS; Lee SY; Yoo JS; Yoo JI; Kim HS; Kim O; Yu JY
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):148-50. PubMed ID: 25139845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia.
    Panesso D; Ospina S; Robledo J; Vela MC; Peña J; Hernández O; Reyes J; Arias CA
    Emerg Infect Dis; 2002 Sep; 8(9):961-5. PubMed ID: 12194774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
    Jakovac S; Bojić EF; Ibrišimović MA; Tutiš B; Ostojić M; Hukić M
    Microb Drug Resist; 2017 Jan; 23(1):122-126. PubMed ID: 27351410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium.
    Mekonen ET; Noskin GA; Hacek DM; Peterson LR
    Microb Drug Resist; 1995; 1(3):249-53. PubMed ID: 9158783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.
    Protonotariou E; Dimitroulia E; Pournaras S; Pitiriga V; Sofianou D; Tsakris A
    J Hosp Infect; 2010 Jul; 75(3):225-7. PubMed ID: 20381193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital.
    Maniatis AN; Pournaras S; Kanellopoulou M; Kontos F; Dimitroulia E; Papafrangas E; Tsakris A
    J Clin Microbiol; 2001 Dec; 39(12):4571-4. PubMed ID: 11724887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Characterization of vanA-Enterococcus faecium Isolates from Wild Red-Legged Partridges in Portugal.
    Silva V; Igrejas G; Carvalho I; Peixoto F; Cardoso L; Pereira JE; Del Campo R; Poeta P
    Microb Drug Resist; 2018; 24(1):89-94. PubMed ID: 28504889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster.
    Arias CA; Torres HA; Singh KV; Panesso D; Moore J; Wanger A; Murray BE
    Clin Infect Dis; 2007 Nov; 45(10):1343-6. PubMed ID: 17968832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.
    Kohler P; Eshaghi A; Kim HC; Plevneshi A; Green K; Willey BM; McGeer A; Patel SN;
    PLoS One; 2018; 13(3):e0193926. PubMed ID: 29566004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implementation of vanA and vanB genes by PCR technique research interest in system (Xpert vanA/vanB CepheidR) closed in a laboratory of microbiology in managing an outbreak to Enterococcus faecium resistant glycopeptide (EfRG)].
    Dekeyser S; Beclin E; Descamps D
    Pathol Biol (Paris); 2011 Apr; 59(2):73-8. PubMed ID: 20828941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of vancomycin-resistant Enterococcus faecium in Argentina.
    Corso AC; Gagetti PS; Rodríguez MM; Melano RG; Ceriana PG; Faccone DF; Galas MF;
    Int J Infect Dis; 2007 Jan; 11(1):69-75. PubMed ID: 16793306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of vancomycin-resistant Enterococcus faecium containing both vanA and vanB gene clusters.
    Dendle C; Ballard SA; Grabsch EA; Gao W; Grayson ML
    J Hosp Infect; 2009 Apr; 71(4):379-81. PubMed ID: 19200618
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
    Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced sensitivity of vancomycin/ampicillin broth enrichment for the detection of
    Heuvelmans M; Sturm PDJ; Rentenaar RJ
    Infect Dis (Lond); 2019; 51(11-12):874-877. PubMed ID: 31469338
    [No Abstract]   [Full Text] [Related]  

  • 19. The emergence of glycopeptide-resistant Enterococcus faecium in a university hospital in southwestern Greece.
    Kolonitsiou F; Mani V; Parikou H; Trakala M; Dimitracopoulos G; Spiliopoulou I
    Chemotherapy; 2004 Nov; 50(5):245-9. PubMed ID: 15528890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study.
    Echeverria-Esnal D; Sorli L; Prim N; Conde-Estévez D; Mateu-De Antonio J; Martin-Ontiyuelo C; Horcajada JP; Grau S
    Int J Antimicrob Agents; 2019 Nov; 54(5):572-578. PubMed ID: 31476435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.